• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Prevalence and outcomes of bacterial co-detections by blood culture among children and adults hospitalized with laboratory-confirm

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2026 May 20:ciag242.
doi: 10.1093/cid/ciag242. Online ahead of print.
Prevalence and outcomes of bacterial co-detections by blood culture among children and adults hospitalized with laboratory-confirmed influenza, Influenza Hospitalization Surveillance Network, 2022-2024

Mark W Tenforde[SUP] 1 [/SUP], Dawud Ujamaa[SUP] 1 [/SUP], H Keipp Talbot[SUP] 2 [/SUP], Alissa C O'Halloran[SUP] 1 [/SUP], Shua J Chai[SUP] 3 4 [/SUP], Darpun Sachdev[SUP] 5 [/SUP], Isaac Armistead[SUP] 6 [/SUP], Nisha B Alden[SUP] 6 [/SUP], James Meek[SUP] 7 [/SUP], Kimberly Yousey-Hindes[SUP] 7 [/SUP], Lucy S Witt[SUP] 8 9 [/SUP], Kyle P Openo[SUP] 8 9 [/SUP], Patricia A Ryan[SUP] 10 [/SUP], Maya L Monroe[SUP] 10 [/SUP], Sue Kim[SUP] 11 [/SUP], Val Tellez Nunez[SUP] 11 [/SUP], Ruth Lynfield[SUP] 12 [/SUP], Melissa McMahon[SUP] 12 [/SUP], Caroline McCahon[SUP] 13 [/SUP], Molly Bleecker[SUP] 14 [/SUP], Grant Barney[SUP] 15 [/SUP], Kaylee Mahoney[SUP] 15 [/SUP], Brenda L Tesini[SUP] 16 [/SUP], Maria A Gaitan[SUP] 16 [/SUP], Denise Ingabire-Smith[SUP] 17 [/SUP], Nancy E Moran[SUP] 17 [/SUP], Melissa Sutton[SUP] 18 [/SUP], Andie Hendrick[SUP] 18 [/SUP], William Schaffner[SUP] 2 [/SUP], Ryan Chatelain[SUP] 19 [/SUP], Ashley Swain[SUP] 19 [/SUP], Shikha Garg[SUP] 1 [/SUP], Catherine H Bozio[SUP] 1 [/SUP]


Affiliations
Abstract

Background: Influenza predisposes individuals to bacterial co-infections, which can result in disseminated infection and bacteremia. We describe the epidemiology and outcomes of blood culture co-detections among persons hospitalized with influenza over two influenza seasons.
Methods: We sampled individuals of all ages from FluSurv-NET, a U.S. population-based surveillance network of persons hospitalized with laboratory-confirmed influenza, during the 2022-2023 and 2023-2024 seasons. Surveillance staff collected information on bacterial blood cultures within 3 days before or 3 days following admission. We described patient characteristics and in-hospital outcomes, stratified by culture positivity, number of positive cultures, and type of co-detection, using unweighted counts and weighted percentages to account for the complex survey design.
Results: Overall, 14,316 patients were included, with a median (interquartile range) age of 57 (14-74) years, 53.6% female, 52.0% non-Hispanic white, and 25.6% with ≥4 categories of underlying medical conditions. Of these, 50.8% had ≥1 blood cultures obtained and 5.2% overall had ≥1 bacterial co-detections. Intensive care unit admission occurred for 9.6%, 19.2%, 31.2%, and 47.9% among patients with no blood cultures, negative cultures, 1 co-detection, and >1 co-detection documented, respectively; in-hospital mortality occurred in 1.5%, 3.3%, 9.4%, and 14.5%, respectively. Among patients with positive cultures, 22.1% had Staphylococcus aureus and 7.5% had Streptococcus pneumoniae co-detections; both were associated with severe illness (with 22.4% in-hospital mortality each).
Discussion: Bacterial co-detections in persons hospitalized with influenza were associated with poor in-hospital outcomes. Efforts to prevent severe influenza and bacterial co-infections, including through vaccination, may reduce substantial morbidity and mortality from influenza.

Keywords: Influenza; bacteremia; blood culture; hospitalization; outcomes.

 
Back
Top